FindTrial
Sign In

clinic role of portal vein-superior mesenteric vein involvement in pancreatic cancer

Anatomical Biological and Conditional Consideration for Resection of Pancreatic Cancer with Isolated Portal Vein Involvement:A retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115349
Enrollment
Unknown
Registered
2025-12-25
Start date
2025-12-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic disease

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 84 Years

Inclusion criteria

Inclusion criteria: From January 1, 2018 to June 30, 2024, we included 262 consecutive patients in our hospital who underwent pancreatic surgery for pancreatic head cancer and were pathologically confirmed to be pancreatic ductal adenocarcinoma, including angiectomy and reconstruction for radical purposes.

Exclusion criteria

Exclusion criteria: Perioperative mortality within 90 days and metastatic disease in pancreatic head carcinoma.

Design outcomes

Primary

MeasureTime frame
overall survival time;—

Countries

China

Contacts

Public ContactDaobin Wang

The First Affiliated Hospital of Soochow University

xfxue@suda.edu.cn+86 180 5189 8769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026